Pirker, Christine <br/><br/>
Response of experimental malignant melanoma models to the pan-Aurora kinase inhibitor VE-465.  [electronic resource] 

 -  Experimental dermatology  Dec 2010 
 - 1040-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1600-0625 
<br/><br/><label>Standard No.: </label>10.1111/j.1600-0625.2010.01182.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Aurora Kinase B<br/>Aurora Kinases<br/>Caspase 7--metabolism<br/>Cell Cycle--drug effects<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Chromosomes, Human--genetics<br/>Drug Synergism<br/>Gene Amplification--genetics<br/>HCT116 Cells<br/>Humans<br/>Melanoma--drug therapy<br/>Neoplastic Stem Cells--drug effects<br/>Piperazines--pharmacology<br/>Polyploidy<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>RNA, Small Interfering--genetics<br/>Tumor Cells, Cultured--drug effects<br/>Tumor Suppressor Protein p53--metabolism